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Contactin-associated protein-like 2 (CNTNAP2) encodes for
CASPR2, amultidomain single transmembrane protein belong-
ing to the neurexin superfamily that has been implicated in a
broad range of human phenotypes including autism and lan-
guage impairment. Using a combination of biophysical tech-
niques, including small angle x-ray scattering, single particle
electron microscopy, analytical ultracentrifugation, and bio-
layer interferometry, we present novel structural and functional
data that relate the architecture of the extracellular domain of
CASPR2 to a previously unknown ligand, Contactin1 (CNTN1).
Structurally, CASPR2 is highly glycosylated and has an overall
compact architecture. Functionally, we show that CASPR2
associates with micromolar affinity with CNTN1 but, under the
same conditions, it does not interact with any of the othermem-
bers of the contactin family. Moreover, by using dissociated
hippocampal neurons we show that microbeads loaded with
CASPR2, but not with a deletionmutant, co-localize with trans-
fectedCNTN1, suggesting that CNTN1 is an endogenous ligand
for CASPR2. These data provide novel insights into the struc-
ture and function of CASPR2, suggesting a complex role of
CASPR2 in the nervous system.
Contactin-associated protein-like 2 (CASPR2)6 is a neuronal
cell adhesionmolecule known in rodents to be necessary for the
clustering of the Kv1 potassium channels at juxtaparanodes (1).
In myelinated nerves, CASPR2 is confined to the juxtaparan-
odal region of the axon where it appears to associate with the
immunoglobulin domains of TAG-1 (transient axonal glyco-
protein-1) to form a scaffold, which clusters the potassium
channels Kv1.1 and Kv1.2 (2–4).
CASPR2 is predicted to be a type I transmembrane protein of
1331 amino acids with the extracellular domain followed by a
single transmembrane domain and a short (48 residues) intra-
cellular domain that terminates with a class II PDZ recognition
motif. Computational predictions suggest that CASPR2 has 12
putative N-linked glycosylation sites and 36 Cys residues likely
making 18 disulfide bonds, forming 8 independently folded
domains: four laminin, neurexin, sex hormone-binding globu-
lin domains (LNS), two epidermal growth factor (EGF)
domains, one discoidin domain, and one fibrinogen-like
domain (Fig. 1A). CASPR2 shares an overall domain organiza-
tionwith-neurexin-1 despite a relatively low amino acid iden-
tity (23% identity,39% similarity). However, distinctive fea-
tures such as a discoidin domain in place of the first LNS
domain and a fibrinogen-like domain in place of the 4th LNS
domain suggest a different overall structural architecture. No
information about the three-dimensional structure of CASPR2,
other than that inferred from sequence homology, is currently
available. Functionally, only TAG-1 (contactin 2 or CNTN2)
has been thus far identified as the extracellular ligand for
CASPR2 (2–4).
Individuals in a cohort of Amish children, homozygous for a
frameshift mutation (single-base G deletion at nucleotide 3709
in exon 22) involving the CNTNAP2 gene, present focal sei-
zures and autistic regression after the onset of the seizures (5,
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6). In these patients, surgical biopsy revealed severe cortical
dysplasia in all children andperiventricular leukomalacia in one
girl, suggesting that CNS myelination was affected. The frame-
shift mutation introduces a premature stop codon at position
1253 (CASPR2–1253*), resulting in a protein that is devoid of
its transmembrane and intracellular domains. In vitro, we show
that CASPR2–1253* folds properly, but it is secreted in the
extracellular space, thus becoming non-functional due to the
fact that the protein is no longer tethered to the cell membrane
(7). In humans, postmortem studies revealed that the jux-
taparanodeswere disrupted inmultiple sclerosis lesions. In par-
ticular, the localization and expression levels of CASPR2 and
TAG-1 were reduced around the lesions and absent in lesion
areas (8) although it remains unclear whether nodal disruption
represents a cause or a consequence of the disease.
Another cell adhesion molecule member of the CNTN fam-
ily, Contactin-1 (CNTN1), has been shown to be essential for
the organization of paranodal regions in myelinated axons.
CNTN1 is composed by six Ig domains followed by four FNIII
domains and a glycosylphosphatidylinositol anchor. At the
amino acid level, the extracellular domain of human CNTN1 is
48.6% identical (74% similar) to the extracellular domain of
humanTAG-1. CNTN1 is required for the cell surface localiza-
tion of CASPR1 where they form a complex during the myeli-
nation process (9–11). CNTN1has also been implicated in hip-
pocampal neurogenesis and cell proliferation as well as in
synaptic plasticity andmemory in the adultmouse (12). Expres-
sion of CNTN1 in both neurons and oligodendrocytes suggests
a role inmyelination, which has been confirmed by low levels of
myelin basic protein in the CNTN1 KOmouse and by its inter-
action with other molecules involved in myelination (13–16).
Here, we present data on the overall architecture of the extra-
cellular domain of CASPR2 and report the identification of
a new endogenous ligand, CNTN1. Intriguingly, although
CASPR2 and CNTN1 expression overlaps at the paranodes
during early development (17) suggesting a functional relation-
ship, the association between the two proteins has never been
reported.We used small angle x-ray scattering, analytical ultra-
centrifugation, and single particle negative stain electron
microscopy to build a structural model of the extracellular
domain of CASPR2. We also show that CNTN1 directly binds
to CASPR2 with micromolar affinity through specific domains.
Remarkably, under the same experimental conditions, we could
not detect CASPR2 association with TAG-1, its putative ligand
(2–4). Moreover, by using dissociated hippocampal neurons
we show thatmicrobeads loadedwith CASPR2 co-localize with
the transfected CNTN1, whereas beads loaded with a deletion
mutant donot, suggesting thatCNTN1 is an endogenous ligand
for CASPR2. Taken together these data provide novel insights
into the structure of CASPR2 and the function of both CASPR2
and the new extracellular ligand, CNTN1.
Experimental Procedures
Cloning of the Proteins—The full-length CASPR2, TAG-1,
and CNTN1 cDNAs were acquired from Open Biosystem
(Thermo Fisher Scientific Inc., Pittsburgh, PA). The entire cod-
ing sequence of the proteins were fully sequenced and inserted
into a pcDNA3.1 vector with either the FLAG or HA epitopes
cloned after the leader peptide. The entire extracellular
domains of CASPR2, TAG-1, CNTN1, and CNTN5 were
cloned into a pCMV6-XL4 expression vector (18). This vector
has a 3C protease cleavage site (LEVLFQ/GP) after the protein
sequence and the beginning of the human Fc sequence. All
CASPR2 and CNTN1 deletion constructs were cloned into
pCMV6-XL4 vector by insertion ofNotI before the first domain
of interest and by XbaI after the last domain of interest (Table
1). TheXbaI site in the vector was placed at the beginning of the
3C protease sequence. The plasmids encoding for CNTN3, -4,
and -6 were kindly provided by Dr. WojWojtowicz, University
of California, Berkeley.
Cell Culture and Transfection—Human embryonic kidney
293 cells lacking N-acetylglucosaminyltransferase I (GnTI)
activity (HEK293 GnTI) were obtained from American Type
Culture Collection (ATCC, Manassas, VA). With these cells
glycosylation remains restricted to a 7-residue homogeneous
oligosaccharide (19). Cells were grown in Dulbecco’s modified
Eagle’s medium (DMEM) supplemented with 2 mM glutamine,
10% (v/v) fetal bovine serum (FBS), maintained in a humidified
incubator at 5% (v/v) CO2 and 95% (v/v) air, and periodically
tested to ensure the absence of mycoplasma contamination.
Stable cell lines were made for each mutant following the cal-
cium phosphate protocol and kept in DMEM, 10% FBS supple-
mented with 500 g/ml of G418 (Geneticin) (Sigma).
Expression and Purification of Proteins—Constructs encod-
ing the entire extracellular domain of CASPR2, CNTN1, or
TAG-1 fused to Fc were transfected into HEK293 GnTI cells
and selected by growth in the antibiotic G418 (20). For protein
expression, cells were maintained at 37 °C and 5% (v/v) CO2 in
Dulbecco’s modified Eagle’s medium containing up to 2% (v/v)
FBS. Proteins were affinity purified using ProteinA-CaptivATM
PriMAB (RepliGen, Waltham, MA) in 150 mM NaCl, 20 mM
Tris, pH 8.0, and subsequently cleaved with 3C protease to
remove the Fc fragment. To ensure homogeneity of the prepa-
ration by absence of degradation or aggregation products, affin-
ity purified proteins were re-purified and buffer exchanged
by gel filtration using a Superdex 200–10/300 DE column
(GE Healthcare) in 150 mM NaCl, 10 mM Hepes, pH 7.4.
Fractions corresponding to CASPR2 were collected and con-
centrated up to 9.6 mg/ml. Aliquots of the purified pro-
teins were separated by SDS-PAGE to check for purity and
integrity. Lysozyme, for use as a scattering standard, was
solubilized in 150 mM NaCl, 40 mM sodium acetate, pH 3.8,
and dialyzed against the same buffer with the final dialysate
TABLE 1
Deletion constructs boundaries for CASPR2 (Uniprot Q9UHC6) and
CNTN1 (Uniprot P12960)
Construct
Protein boundaries
(amino acid numbers)
CASPR2 D1 28–184
CASPR2 D1–6 28–962
CASPR2 D3–6 376–962
CASPR2 D6–8 789–1218
CASPR2 D2–3 187–557
CNTN1 Ig1-Ig6 21–612
CNTN1 Fn1-Fn4 603–996
CNTN1 Ig5-Fn2 396–808
CNTN1 Ig5-Fn1 396–704
CNTN1 Ig6-Fn1 507–704
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used for solvent blank measurements. Protein concentra-
tions were determined at 280 nm using extinction coeffi-
cients expressed as E0.1% for CASPR2 (1.516 liter/g) calcu-
lated using Protparam (21).
N-terminal Sequencing and Mass Spectrometry Deter-
minations—Edman degradation was performed by the Molec-
ular Structure Facility core at the University of California,
Davis. Mass spectrometry determination of CASPR2–1261
mass was determined on a PE Biosystems Voyager DE-STR
instrument (Framingham,MA) at the BiomolecularMass Spec-
trometry Facility, University of California, San Diego.
Analytical Ultracentrifugation—All samples were measured
in a Beckman Optima XLI at the Center for Analytical Ultra-
centrifugation of Macromolecular Assemblies (CAUMA) at
The University of Texas Health Science Center at San Antonio
(UTHSCSA). All samplesweremeasured in a single experiment
at 40,000 rpm in an AN60Ti rotor and at 20 °C, using standard
epon 2-channel centerpieces in 10 mM Hepes buffer, pH 7.4,
and 150mMNaCl. Protein concentrations were 1.24, 2.51, 4.19,
and 10.68M, corresponding to 0.31, 0.63, 1.05, and 2.68 absor-
bance units at 280 nm (6.37 fringes), respectively. The three
lowest concentrations were measured using absorbance optics
in intensitymode at 280 nm,whereas the highest concentration
wasmeasuredwith interference optics (see Ref. 22 for details on
intensity measurements, which allow up to two samples to be
measured per cell). All data were analyzed using UltraScan-III,
revision 2029 (23). Time and radially invariant noise was
removed during analysis with the two-dimensional spectrum
analysis (24), and diffusion-corrected sedimentation coefficient
distributions were calculated with the enhanced van Holde-
Weischetmethod (25). Parsimonious regularization of the two-
dimensional spectrum analysis results and molecular weight
determinations were performed with the genetic algorithm
analysis (26, 27). The genetic algorithm solution is then ana-
lyzed by Monte Carlo analysis to determine confidence limits
for the determined parameters (28). All calculations were per-
formed on the Lonestar cluster at the Texas Advanced Com-
puting Center at the University of Texas at Austin, and on the
Jacinto cluster at the Bioinformatics Core Facility at UTHSCSA
(29). Partial specific volumewas calculated based on amino acid
composition using UltraScan based on the method by Durch-
schlag (30) accounting for total carbohydrate, and were found
to be 0.7217 cm/g.
Small Angle X-ray Scattering Data Analysis of CASPR2—
SAXS data recorded as I(q) versus q, where q 4sin/ (2 is
the scattering angle and  the x-ray wavelength, 1.54 Å, CuK)
were collected from protein samples and matched solvent
blanks (ultrafiltrate buffers for CASPR2 and last step dialysate
for lysozyme) at 20 °C using an Anton Paar SAXSess line colli-
mation instrument at the University of Utah. Scattering inten-
sities were detected on two-dimensional position-sensitive
image plates (10mm slit and integrationwidth) and data reduc-
tion was performed using SAXSQuant1D (Anton Paar propri-
etary software) as described in Ref. 31. The final one-dimen-
sional scattering profiles for each protein in solution were
determined by subtracting the matched solvent scattering con-
tributions from the respective sample scattering and applying a
geometry correction (10-mm slit and integration width) to take
into account smearing effects caused by the slit collimation of
the x-ray source. A concentration series for CASPR2 was mea-
sured between 1.0 and 9.6 mg/ml in 10 mM Hepes, pH 7.4, and
150 mM NaCl.
Guinier plots (ln(I(q)) versus q2)were initially evaluated using
the program SAXSQuant1D. The Rg and I(0) for CASPR2 and
the lysozyme standard were determined from the geometry-
corrected SAXS data using linear regression and extrapolation
of ln(I(q)) versus q2 in the very low angle region of the plot (qRg
1.3). The probable inter-atomic distance distribution of vector
lengths for each of the proteins, or pair distance distribution
function, p(r), were calculated using the indirect Fourier trans-
form method of Svergun as implemented in the program
GNOM (32). This method also incorporates a geometric cor-
rection factor that takes into account the slit geometry of the
instrument to produce a real-space atompair distance distribu-
tion. Structural parameters derived from the p(r), including
I(0), Rg, and Dmax were determined for the CASPR2 proteins
and lysozyme standards at various protein concentrations.
The determination of I(0) from the protein samples was used
to evaluate sample monodispersity against a lysozyme stan-
dard.Dilutemonodisperse proteins of the same x-ray scattering
(electron) density in solution adheres to the relationship,
K 
I0
MWc
(Eq. 1)
where MW is the calculated (expected) molecular mass of the
scattering protein (kDa), c is the protein concentration (mg/
ml), and K is a constant. Lysozyme is known to be monomeric
and monodisperse under the conditions measured (33). Thus
theK value derived from the lysozyme I(0) data can be used as a
standard to evaluate the molecular mass of CASPR2 provided
that protein concentrations are known within5%. When the
K value of the lysozyme data is normalized to 1, it is found that
the resulting K for the CASPR2 constructs spanning the con-
centrations series is 1.16, i.e. themolecularmass of theCASPR2
proteins are 16% higher than the calculated molecular mass of
the peptide chain. However, this molecular mass was within
5% of the molecular mass calculated by MS.
Ab Initio and Rigid BodyModeling—DAMMIN (34) ab initio
bead modeling was performed against CASPR2 SAXS data
using the ATSAS online server. Ten individual modeling runs
were performed. The spatial alignment and averaging/bead
occupancy corrections were calculated using DAMAVER and
DAMFILT.
Rigid body modeling using CORAL was set up using the
SWISS-model derived homology models for each domain of
CASPR2with the addition of bound glycans. The glycanmoiety
corresponding to Man5GlcNAc2,
Man-Man-Man

GlcNAc-GlcNAc-Man

Man
Reaction 1
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were added to Asn residues using the program GLYCOSYLA-
TION that is part of the newATSAS2.7.1 software release.7 The
Asn amino acidsmodified have a combined glycanmass of15
kDa and are reported below. We have used the program GLY-
COSYLATION tomodel each heptasaccharide at eachN-linked
attachment site (Table 2) as a rigid body during Coral refine-
ment.GLYCOSYLATION draws from database of glycan struc-
tures typically found on glycosylated proteins.
CORALmodeling was performed using the glycan-modified
CASPR2 domains as rigid bodies, with 15–20 Å distance con-
straints imposed between the C and N termini during refine-
ment. Refinement was performed against the desmeared (i.e.
geometry-corrected) SAXSdata across the concentration series
data for CASPR2. Twenty individual CORAL modeling runs
were performed. The final fits against the SAXS data of the
Casper models were assessed using CRYSOL, with a back-
ground constant correction enabled. In all instances (ab initio
and CORALmodeling) discrepancies between the final models
and data were evaluated using the traditional reduced 	2
test and the probability of similarity obtained from variance/
covariance correlation map assessments (35). The SAXS data
and resultingmodels have been deposited to the SASBDB data-
base (36) with accession code SASDBR2.
Homology Modeling of CASPR2—Swiss Model Server was
used to obtain structural templates for all of CASPR2 domains.
A total of eight sequences (ranging between 2 and 60 residues)
linking various LNS and epidermal growth factor domains did
not have a suitable three-dimensional template (Table 2).
Negative-stain Single Particle Electron Microscopy (EM)
Epitope Tagging—PurifiedCASPR2 (0.05–0.1mg/ml) in 10mM
Hepes, pH 7.4, and 150 mMNaCl solution was applied to glow-
discharged carbon-coated grids and negatively stained with
0.75% uranyl formate as described (37). EM images for class
averages were collected using a Jeol 1200 operated at 80 kV on
Kodak film camera at a magnification of60,000. The range of
defocus values was 0.5 to 1.1 m under focus. Approximately
4,000 particles were analyzed using multivariate statistics,
image classification, and averaging. Particles were selected
interactively using the WEB display program. A second pass
selection of properly centered particles was done interactively,
and particles were aligned and classified by reference-based
alignment and the Kmeans classification (51 classes) using the
SPIDER suite (38).
Biolayer Interferometry (BLI) Analysis—BLI binding experi-
ments were conducted using a BLItz instrument (ForteBio,
Menlo Park, CA) at room temperature. Anti-human Fc capture
Biosensors were pre-wetted for 10 min in 300 l of 10 mM
Hepes, pH 7.4, 150 mM NaCl, 10 mM CaCl2, 10 mMMgCl2, and
5% (w/v) BSA buffer prior to use. Subsequently, the sensor tips
were incubated with conditioned medium of transiently trans-
fected CASPR2 or CNTNs for 10 min to capture the expressed
protein. The binding reaction occurred in a 4 l drop contain-
ing various concentrations of purified proteins under agitation.
Both association and dissociation were allowed to occur for
90 s.Nonspecific binding and instrument noisewere subtracted
by using a sensor tip saturated with Fc fragment alone.
Cell-based Binding Assay—HEK293 cells were transfected
with HA_CASPR2 or FLAG_CNTN1 FL following calcium
phosphate protocol in a 60 mm plate. After overnight incuba-
tion, cells were transferred to 24-well plates on poly-D-lysine-
coated glass coverslips (12 mm diameter) at a density of 3.5 
104 cells/well. After6 h of incubation at 37 °C, 1–5 M puri-
fied CASPR2 or CNTN1 were added to the cells in media
(DMEM, 0.1% (w/v) bovine serum albumin (BSA), 20 mM
Hepes, pH 7.4) and the cells were incubated at 4 °C for 16 h.
After two washes with cold DMEM and one with PBS, cells
were fixed with cold 4% paraformaldehyde for 15 min at 4 °C.
Cells were washed 3 times with PBS and incubated with anti-
human IgG (1:1000, Santa Cruz Biotechnology, Dallas, TX) in
blocking solution (2% (w/v) normal donkey serum, 2% (w/v)
BSA in PBS) for 1.5 h at room temperature. After three washes
with PBS, anti-HA (1:1000, Roche, Basel, Switzerland) or anti-
FLAG (1:5000, Sigma) was added to the cells in blocking buffer
solution and incubated for 2 h followed by three washes with
PBS and incubation of secondary antibodies conjugated to
Alexa Fluor-488 and Cy3 (1:500, Jackson ImmunoResearch,
West Grove, PA) for 1 h. Coverslips were then mounted onto
glass microscope slides using Fluoromount G (Southern Bio-
technology, Birmingham, AL) and analyzed with a Zeiss LSM
700 confocal microscope with a Cooke SensiCam charge-cou-
pled device (CCD) cooled camera fluorescence imaging system.7 M. Franklin and M. Petoukhov, unpublished data.
TABLE 2
CASPR2 homology model domain boundaries
N-linked glycosylation sites are indicated in yellow. Fragments not included in ho-
mology models are underlined.
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Neuronal Cultures and Transfection—Mouse hippocampi
prepared from C57BL/6 at postnatal day 0 (P0) were collected
in Ca2	,Mg2	-free Hanks’ balanced salt solution containing
0.01% (w/v) Hepes and incubated with 0.6 mg/ml of papain
(Worthington, Lakewood, NJ) for 20 min at 37 °C. After incu-
bation with 1 mg/ml of DNase for 5 min, hippocampi were
washed with plating medium (basal medium Eagle containing
0.45% glucose, 1 mM sodium pyruvate, 2 mM L-glutamine, 10%
(w/v) FBS, 100 units/ml of penicillin, and 100g/ml of strepto-
mycin). Neurons were dissociated by trituration and plated on
24-well plates on poly-D-lysine-coated glass coverslips (12 mm
diameter) at a density of 10 104 cells/well. Hippocampal neu-
rons were cultured in Neurobasal medium supplemented with
2% (v/v) B-27 (Invitrogen), 1% (v/v) Glutamax, 100 units/ml of
penicillin, and 100 g/ml of streptomycin in a humidified
atmosphere containing 5% (v/v) CO2 and 37 °C. Neurons were
transfected with the appropriate plasmid using Lipofectamine
2000 following the manufacturer’s protocol (Invitrogen).
Bead Adherence Experiments—Non-fluorescent streptavi-
din-labeled 1-mmagnetic beads (Thermo Scientific, aqueous
suspension at 10 mg/ml, Waltham, MA) were washed in PBS
containing 100 g/ml of BSA (PBS/BSA) and incubated with
biotin-conjugated anti-human IgG-Fc (Jackson Immuno-
Research,West Grove, PA) at 1.2g of antibody perl of beads
in PBS/BSA at 4 °C for 2 h. The beads were then rinsed with
PBS/BSA and further incubated in each of the soluble
CASPR2-Fc constructs in conditioned DMEM at 4 °C over-
night. After an additional wash in PBS/BSA, the beads were
sprinkled onto hippocampal neuron cultures (1 l of beads/
coverslip) and left for 24 h in the CO2 incubator, and subse-
quently fixed.
Immunocytochemistry—Neurons at variable days in vitro
(ranging from days in vitro 7 to 12) were fixed in 4% (v/v) para-
formaldehyde in PBS for 15 min. Cells were then incubated in
blocking solution (PBS containing 0.1% (v/v) Triton X-100, 2%
(v/v) normal sheep serum, and 0.02% (w/v) sodium azide) for
1 h. All antibodies used were diluted in blocking solution. Pri-
mary antibodies used were: anti-FLAG (1:5000, Sigma)
and anti-microtubule-associated protein-2 (1:5000, Abcam,
Toronto, ON). Cells were incubated in primary antibody-con-
taining solution at 4 °C overnight, then washed with PBS three
times. Secondary antibodies conjugated to Alexa Fluor-488,
Cy-3, and 647were generated in donkey toward the appropriate
species (1:500, Jackson ImmunoResearch, West Grove, PA).
Coverslips were then mounted onto glass microscope slides
using Fluoromount G (Southern Biotechnology, Birmingham,
AL). Labeled cells and magnetic beads were visualized by im-
munofluorescence on a Zeiss LSM 700 confocal microscope
with a Cooke SensiCam charge-coupled device cooled camera
fluorescence imaging system. The conditions for capturing
images and the settings for thresholds were kept identical
throughout each series of experiments.
Results
Biochemical Characterization of the Purified Extracellular
Domain of CASPR2—The construct generating the secreted
extracellular domain ofCASPR2 (Fig. 1A) extends from the first
methionine of the leader peptide to residue Ser-1261
(CASPR2–1261) located immediately before the transmem-
brane domain. As the secreted CASPR2 protein is expressed
using the native leader peptide, we wanted to determine the
N-terminal sequence of the mature protein. Five cycles of
FIGURE 1.Diagramof theCASPR2 constructs andhydrodynamic characterizationof thepurified extracellular domainof CASPR2–1261.A, top, domain
organizationof the full-lengthprotein.N andC, N andC termini of thewild type, full-lengthprotein; L, leader peptide;Disc, discoidin domain; LNS1 to 4, laminin,
neurexin, sex-hormone-binding globulin domains; E1 and E2, epidermal growth factor domains; F, fibrinogen-like domain. The intracellular domain (ICD) is on
the right side of the cell membrane. For CASPR2–1261, 1–8 are the domain numbers used throughout the manuscript; Fc, Fc domain of human IgG. B, size
exclusion chromatography trace of purified CASPR2–1261. Top margin shows column calibration: 1, thyroglobulin (670 kDa); 2, 
-globulin (158 kDa); 3,
ovalbumin (44 kDa); 4,myoglobin (17 kDa); 5, vitaminB12 (1.35 kDa). Inset, Coomassie Blue stainingof a CASPR2–1261 sample composedof themainpeakwith
the relative molecular masses. C, G(s) distribution plots from the enhanced van Holde-Weischet analysis of sedimentation velocity experiments of four
concentrations of CASPR2–1261 over 10-fold dilution (10.68 to 1.24 M).
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Edman degradation unambiguously showed that CASPR2
starts at Ala-28, consistent with predictions using bioinformat-
ics tools. Because CASPR2 is highly glycosylated, to simplify
structural analyses, we expressed it using glycosylation defi-
cient HEK293 GnTI cells, which only adds a Man5GlcNAc2
(mass  1234 Da) to each N-linked glycosylation site.
CASPR2–1261 was subjected to accurate mass determination
by MALDI-TOF. Whereas the peptide mass of the expressed
protein is calculated to be 138,481 Da, mass spectrometry of
CASPR2 revealed a molecular mass of 153,229 Da. The differ-
ence of 14,748 Da between the two values is explained by the
glycosylation of the protein. The occupancy of the potential
N-linked sites was therefore estimated to be 11.9 units permol-
ecule on average, a value consistent with 12 potential N-linked
glycosylation sites. Therefore, these data allowed us to estimate
the overall oligosaccharide occupancy of themature, expressed
protein. To ensure sample monodispersity for subsequent
experiments, the purified CASPR2–1261 was analyzed by size
exclusion chromatography (SEC), yielding a single peak eluting
at 12.6 ml, corresponding to an apparent molecular mass of
140 kDa, consistent with the determined molecular mass of
153 kDa (Fig. 1B).
Analytical Ultracentrifugation Indicated That CASPR2 Is a
Monomer in Solution—To further characterize oligomerization
behavior, mass, and shape distributions of CASPR2–1261, we
performed sedimentation velocity experiments over four load-
ing concentrations from 1.24 to 10.68 M. The typical half-
parabola shape seen for reversible monomer-dimer equilibria,
and an increase in sedimentation coefficients with an increase
in concentration expected for a dimerization are absent (39).
Analysis of the sedimentation velocity experiment by the van
Holde-Weischet method (25) revealed identical sedimentation
coefficient distributions for all concentrations, with 
90% of
the sample displaying a homogeneous species with a sedimen-
tation coefficient consistent with the monomeric molecular
weight, and, in these samples, a small amount (10%) of aggre-
gate. A small concentration dependent non-ideality effect was
evident, which reduced the S value slightly at higher concentra-
tions (7.76S for 1.24 M, 7.76S for 2.51 M, 7.62S for 4.19 M,
and 7.04S for 10.68M). Such an effect is not unexpected, espe-
cially for glycosylated proteins, where sugar moieties can con-
tribute to crowding and interaction effects. The results for the
van Holde-Weischet analysis are summarized in Fig. 1C. To
further confirm the molecular weight of the major species we
performed a global genetic algorithm,MonteCarlo analysis (27,
28), on the three lower concentration samples. This analysis
revealed a molecular mass of 150.1 kDa for the major species
(95% confidence intervals: 142.8 and 157.4 kDa), which is in
excellent agreement with the monomer molecular weight
determined byMALDI-TOF, and a frictional ratio of 1.39 (95%
confidence intervals: 1.35 and 1.43), indicating a mostly globu-
lar conformation. Taken together, these observations strongly
indicate that the extracellular domain of CASPR2 is mono-
meric in solution and well folded.
Small Angle X-ray Scattering—SAXS data were measured
from samples consisting of the entire extracellular domain of
CASPR2 (CASPR2–1261) (Fig. 1 and Table 3). Guinier plots of
the SAXS data are linear (40) (Fig. 2A, inset) and there is no
significant concentration dependence to the radius of gyration
(Rg, 45 Å) or normalized forward scattering intensity at zero
angle, I(0) (Fig. 2, B and C). Furthermore, there is good agree-
ment between Rg values determined by Guinier and P(r)
analysis.
P(r) analysis also indicates that the maximum linear dimen-
sion (dmax) value of CASPR2–1261 is 140 Å (Fig. 2D), and the
slightly extended asymmetry to the right side of the peak is
consistent with a relatively compact multidomain protein.
Using lysozyme as a standard (33) and relative I(0) values, the
molecular mass of CASPR2 in solution was estimated to be 160
kDa, consistent with the monomeric form of the protein mea-
sured by mass spectrometry (153.2 kDa). The slightly higher
than the expected (5%) molecular mass is likely due to the
influence of N-linked glycans. Taken together, these solution
scattering measurements demonstrate that these protein prep-
arations are free of nonspecific aggregation and inter-particle
interference effects and thus suitable for more detailed struc-
tural analysis.
Ab Initio Modeling—To obtain an initial assessment of the
three-dimensional shape of the extracellular domain of
CASPR2, we used an established ab initio bead-modeling
approach implemented in the DAMMIN software package ver-
sion 5.3 (41). With this procedure, we derived an ensemble of
molecular shapes that best describe the scattering data. All of
the models for CASPR2–1261 had an excellent fit to the data
(	2: 0.76–0.77: correlation map p 
 0.01) (35) and the nor-
malized spatial discrepancy values of 0.77–0.90 (42) indicated
reasonable correspondence between each shape reconstruction
in that they share an overall compact shape, but with differ-
ences in the detailed shape boundaries. Analyses of the individ-
ual bead models (Fig. 2E) revealed structural features in com-
monwithmodels derived from rigid bodymodeling procedures
TABLE 3
SAXS parameters and statistics
Data collection parameters CASPR2–1261
Instrument SAXSess (Anton Paar)
Beam geometry 10 mm slit
Wavelength (Å) 1.5418
q range (Å1) 0.01297–0.35140
Exposure time (minutes) 30
Concentration range (mg ml1) 9.570–1.0
Temperature (celsius) 20
Structural parameters
Protein concentration (mg/ml) 9.570
I(0) (cm1) from P(r) 1.188	 0.0060
Rg (Å) from P(r) 46.11	 0.226
I(0) (cm1) from Guinier 1.199 0.007
Rg (Å) (from Guinier) 44.809 1.633
Dmax (Å) 145
Porod volume estimate (Å3) 298,433
Dry volume estimated from sequence (Å3) 167,557
Molecular mass determination
Partial specific volume (cm3 g1) 0.7156
Molecular mass, kDa (from I(0) compared with
lysozyme)
160
Calculated monomeric mass from
sequence (Da)
138,551/153,229 (MS)
N-Linked glycosylation sites (potential) 12
Software employed
Primary data reduction Saxquant 1d
Data processing Gnom
Ab initio analyses Gasbor
Validation and averaging Damaver
Rigid body modeling Coral
Computation of model intensity Crysol
Three-dimensional graphic representation PyMol
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and from single particle EM (see below) showing thatCASPR2–
1261 maintained a compact overall architecture.
Rigid body Modeling—At present, no high resolution struc-
ture of any CASPR2 domain is available. Therefore, using the
SWISS MODEL server, homology models were built for each
domain, with 90% overall coverage of the extracellular
domain (1107 over 1234 amino acids) (Table 2). To obtain an
atomistic structural model of CASPR2 that best fits the SAXS
data the program CORAL (41) was used. This program simul-
taneously refines the relative orientation and positioning of
FIGURE 2. Basic scattering parameters and modeling of the extracellular domain of CASPR2–1261. A, desmeared scattering profile of the highest
concentrations of CASPR2–1261. Red line shows the fit of one of the models shown in E (model 4) overlaid with the raw data, showing excellent agreement
between the two curves. Inset: Guinier analyses where the solid red line represents the linear fit through the Guinier region. B, CASPR2–1261 Rg versus
concentration of the sample. C, CASPR2–1261 concentration dependent of the normalized forward scattering intensity at zero angle, I(0). Both parameters
remain linear as expected by optimal protein preparationwith virtually no non-ideal effects.D, the P(r) functions of CASPR2–1261, indicates the distribution of
all interatomic distances and the maximum dimension of the particle in Å. Statistical quality of the data can be assessed by the standard error bars; some
estimated errors are smaller than the symbols. See also Table 3 for a complete report of other SAXS parameters. E, overlay of six distinct DAMMIN models
obtained by ab initio reconstructions (white bead representation) with six models obtained with rigid bodymodeling (ribbon representation) to highlight the
similarity between the model pairs. N and C, N- and C-termini of the protein.
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individual homology modeled domains as rigid bodies against
the SAXS data, while accounting for amino acids not present
in the coordinate files, by modeling them as self-avoiding
polyglycine inter-domain linkers. The resulting CORAL mod-
els (	2: 0.42–1.24: correlation map p 
 0.01) (Fig. 2E, ribbon
representation) spatially superimpose with individual ab initio
beadmodels and showa similarly compact architecture. Several
models were obtained that fit the SAXS data equally well, had a
dmax of140Å, and shared the common features of being over-
all compact, with a three-clover leaf at one end and two
domains at the other end. However, probably due to its overall
more compact architecture compared with -neurexin, SAXS
data did not allow us to model the N- or C-terminal ends of the
protein always in the same position with respect to the other
domains (Fig. 2E).
Although the model of the central fibrinogen-like domain is
missing eight amino acid residues, its N- and C- terminal ends
are spatially proximal, likely forcing the proximal and distal
domains of CASPR2 into a compact overall architecture. This is
in contrast with the extended shape of-neurexin that contains
a central LNS domain in place of the fibrinogen-like domain
(43). Finally, to best approximate the molecular volume/mass
contributions of the highly hydrated sugar moieties, N-linked
glycanmoieties were added to all theNx(S/T) sequons available
in the homology modeled domains during rigid body modeling
(Fig. 3). Thismodel highlights the volumeof theMan5GlcNAc2
carbohydrate occupancy of this molecule and suggests that
when native glycosylation is added in the Golgi apparatus, an
even larger volume occupied by the sugar moieties can affect
the overall flexibility of the protein and the interaction with its
ligand(s).
Single Particle Negative Staining EM—SAXS provides a time
and ensemble average representation of the conformation of
macromolecule in solution, whereas single particle EM can
directly provide information regarding individual structures.
To evaluate potential structural variability in the extracellular
domain of CASPR2, the purified protein was fractionated by
size exclusion chromatography and the fraction corresponding
to the center of the peak was imaged using a transmission EM
(Fig. 1B). CASPR2 particles were monodisperse and homoge-
neous in size and all shared a compact overall architecture, in
good agreement with all other experiments presented thus far.
Raw single particle EM imaging of the entire extracellular
domain of CASPR2 showed that individual particles adopted an
assortment of conformations illustrated by a variety of shapes
(Fig. 4, A and B). After aligning and averaging4,000 particles
and classifying them into 51 classes, themajority clearly showed
the presence of five distinguishable modules, which, judging
from their size (40 Å diameter), corresponded to the discoi-
din and the four LNS domains (Fig. 4, B and E).
The central domain between residues 592 and 798 that
contains a small fibrinogen-like sequence of unknown struc-
ture could not be identified. As for the two epidermal growth
factor domains (35 amino acids each) their small size did not
allow us to specifically identify them with this technique, as
shown in similar experiments used to determine the -neur-
exin structure (43). Although these images do not allow us to
readily distinguish between conformational diversity and dif-
ferent positioning of the protein on the grid, numerous class
average images of the extracellular domain of CASPR2
clearly showed features similar to the ab initio and rigid body
modeling (Fig. 4, C and D). In particular, we could distin-
guish the clover leaf arrangement at one end and two
domains at the other end, suggesting that the three domains
constitute the N-terminal region of the protein, whereas the
two-domain region likely represents the third and fourth
LNS domains. In these experiments, the maximum dimen-
sion of the particles remains highly consistent with the SAXS
measurements (145 Å). Taken together, all biophysical
experiments shown here, including SEC, analytical ultracen-
trifugation, SAXS, and single particle EM illustrated that the
extracellular domain of CASPR2 has an overall compact
architecture. As all these data come from independent bio-
FIGURE 3. SAXS rigid body model of CASPR2. Single rigid body model (model 4 of Fig. 2E) in white ribbon representation. The model is shown in two
orientations to highlight the carbohydrate contribution (blue spheres, Ref. 50) to the total mass of the protein and the few residues missing in the
modeling procedures (orange spheres). Red numbers refer to the individual domains as described in the legend to Fig. 1A. N and C, N and C termini of the
protein.
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physical techniques, they strongly suggest that the observed
three-dimensional organization is relevant in vivo.
CNTN1 Is a Novel Ligand for CASPR2—Testing the binding
of CASPR2 to the contactin family of proteins (which includes
the putative ligand TAG-1 of CASPR2), we found that contac-
tin 1 (CNTN1) specifically associates with the extracellular
domain of CASPR2. Using BLI we immobilized CNTN1–
993-Fc on an anti-human Fc sensor and used the purified
extracellular domain of CASPR2–1261 to directly test the asso-
ciation (Fig. 5A). The binding between the extracellular
domains of CASPR2 andCNTN1displayed fast association and
dissociation rates, with a calculated dissociation rate constant,
KD, of14 M. When the phases were reversed by immobiliz-
ing CASPR2-Fc to the sensor tip and using purified CNTN1–
993 (Fig. 5B), similar results were obtained.
To further investigate their association and determine
whether CNTN1 is able to bind CASPR2 directly on the cell
surface of live cells we performed a cell-based binding assay.
HEK293 cells expressing the full-length CASPR2 HA-tagged
were incubated with up to 5 M purified CNTN1–993-Fc and
FIGURE 4. Single particle EM of the extracellular domain of CASPR2. A, raw image of the CASPR2–1261 particles before alignment. Scale bar, 50 nm. B,
selection of representative class averages, which show five visibly distinct domains. Scale bar, 15 nm. The size of each box of the class averages is 32 32 nm.
C and D, overlay of one EM class average to ab initio reconstruction (C) or one of the rigid body models obtained with Coral (D) to show the high similarity of
shapes andmodels obtainedwith these independent procedures. In this panel, wehave labeled the domains resulting from the rigid bodymodeling. Scale bar
is 7.5 nm. E, additional 51 single particle EM classes show the breadth of the conformational variability and orientation of the protein on the grid of the
extracellular domain of CASPR2.
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we found that the extracellular domain of CNTN1 bound to
CASPR2 expressed on the cell surface. As a positive control, we
incubated HEK293 cells expressing Neuroligin 1 with 1 M of
purified -neurexin-Fc (20, 44) or 5 M of the Fc portion alone
as a negative control (Fig. 5C).
CASPR2 Interacts with Multiple Domains of CNTN1—Hav-
ing confirmed the association of CASPR2 and CNTN1 by two
independent techniques, and measured the apparent affinity,
we sought to determine which domain of either protein is
responsible for the interaction.We engineered various deletion
constructs for both CASPR2 and CNTN1 (see Table 1 for con-
struct boundaries), expressed them in HEK293 cells, and used
BLI to ascertain whether they retained their binding properties.
Using this strategy we narrowed down the associating domains
for CNTN1 as the central Ig5/FN1 construct (Fig. 6, A, C, and
D). The shorter construct Ig6/FN1 did not show measurable
association, as well as either half (the six Ig domains or the four
FN3 domains) of the protein (Fig. 6,A and C). Interestingly, for
CASPR2, the construct encoding D1–6 was the shortest con-
struct that showed CNTN1 association. Although we tested
smaller fragments such asD1, D2–3, D3–6, andD6–8, the lack
of binding of these fragments suggests that theminimal binding
domain of CASPR2 is composed by the first six domains
together (Fig. 6, B–D).
To confirm these results, we resorted again to the cell-based
binding assay using WT CASPR2 expressed on the surface of
HEK293 cells and soluble CNTN1-Ig5/Fn1. We also reversed
the experiment and used WT CNTN1 and soluble CASPR2-
D1–6. In both cases associationwas confirmed and the Fc alone
was used as a negative control (Fig. 6E).
CNTN1 Is anEndogenousReceptor forCASPR2 inHippocam-
pal Neurons—We next wanted to determine whether CNTN1
is a receptor for CASPR2 in cultured primary neurons.
CASPR2–1261-Fc fragments were loaded onto microbeads
through the Fc portion (or the Fc alone as a control) and sub-
sequently incubated with hippocampal neurons after 14 days in
vitro. After washing and fixing the plated neurons, only the
CASPR2 fragments that interactedwith a ligand exposed on the
surface of the neurons remained bound and could be visualized.
Microtubule associated protein-2 was used as a marker for the
neurons (Fig. 7A). In the absence of a ligand (e.g. beads loaded
with the Fc control), beads were removed with the washes (Fig.
FIGURE 5. CASPR2 and CNTN1 association experiments. A, BLI experiment of the association between the extracellular domain of CNTN1–993 and the
purified CASPR2–1261. Five concentrations of CASPR2 (75 to 4.7M in 2-fold dilution) were used to determine the affinity of the association, calculated in the
inset. The global association and dissociation rate constants obtained from these curves are: ka 1.461 10
4
M
1 s1 and kd 3.29 10
1 s1. B, SEC profile
of purifiedCNTN1used for BLI experiments. The elution volumeof this protein indicates that, similarly to TAG-1, CNTN1 is likely a dimer in solution.C, cell based
binding assay between the HA-CASPR2 full-length transfected in HEK293 cells and the purified CNTN1–993 added at 3 M. Fc- and HA-CASPR2 was used as a
negative control, whereas NLGN1/-NRXN1 were used as a positive control. Hoechst stain was used to visualize all cells. Scale bar 10 m.
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FIGURE 6. Determination of the associating domains between CASPR2 and CNTN1. A, BLI curves of purified CASPR2 (30 M) bound to CNTN1–993 or
shorter constructs immobilized on a sensor tip, highlighting the associating constructs. B, BLI curves of purified CNTN1–993 (30M) with immobilized various
fragmentsofCASPR2–1261or shorter constructs highlighting theassociating constructs.C,diagramof the variousCASPR2andCNTN1deletion constructs that
were tested by BLI and their binding result. Dotted lines, no detectable binding; solid lines, associating fragments. D, Western blot (anti-human Fc) of the
deletion constructs used to determine the minimal binding cassette by BLI. E, cell-based binding assay between the transfected HA-CASPR2 full-length or
FLAG-CNTN1 full-length with the purified fragments at 3M that still retain binding by BLI. The Fc fragment alonewas used as negative control. Hoechst stain
was used to visualize all cells. Scale bar 10 m.
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7B). To ascertainwhetherCNTN1was a ligandwhen expressed
on the surface of neurons and glial cells, we transfected WT
CNTN1 in hippocampal neurons and repeated the binding
experiments using CASPR2–1261 or the deletion constructs
CASPR2-D3–6 as a negative control (Fig. 7, C andD). Under
these conditions, beads loaded with CASPR2–1261 were
clearly co-localizing with the transfected CNTN1 neurons,
whereas beads loaded with CASPR2-D3–6 were removed
with the washes similarly to the Fc alone control condition.
Because only the domains positive for the CNTN1 associa-
tion in vitro were bound to the neurons in culture, this
experiment suggests that CNTN1 is one endogenous ligand
for CASPR2.
Binding of CASPR2 with the Other CNTNs—To test whether
CASPR2 binds to other members of the CNTN family, we
expressed and tested the binding of the extracellular domain of
CASPR2 with CNTN1 through CNTN6 using BLI. Despite a
40–49% amino acid identity among the CNTN isoforms, we
did not detect any association with any other CNTN family
member, including its putative ligand TAG-1 (CNTN2) (Fig. 8,
A andB) (2–4). Although the binding experiments with TAG-1
were replicated in various buffer conditions (e.g. with or with-
out Ca2	 andMg2	 and with different batches of proteins), we
never detected any interaction.
Discussion
Because of the importanceofCASPR2 inhumanbraindevelop-
ment (45) and to complement our previous biochemical work (7)
we sought to understand the structure of CASPR2 and themolec-
ular aspects of the interaction of CASPR2 with its new ligand
CNTN1. Using a combination of independent biophysical and
biochemical techniques we report heremajor new findings on the
overall architecture of the extracellular domain ofCASPR2 and its
associationwithCNTN1.Wedescribehere the first, toourknowl-
edge, structural models of the extracellular domain of CASPR2:
despite similarities in its domain composition and organization
withNRXN, our data indicate that the twoproteins have distinct
tertiary structures, as the extracellular domain of CASPR2 is com-
pact with a likely dominant three-domain clover leaf feature with
two domains somewhat extended. In contrast, the extracellular
domain of NRXN displays a significantly more elongated,
“L-shaped” conformation (43, 46, 47). Second, our single particle
EM data suggests that within an overall compact architecture the
extracellular domain of CASPR2 may adopt a variety of tertiary
FIGURE 7.Hippocampal neurons in culture experiment suggesting an interaction between CASPR2 and endogenous CNTN1. A, 1-mmagnetic beads
were loaded with CASPR2–1261 and incubated with hippocampal neurons before being fixed and stained. Note that the beads remain attached on the
neuronal branches. B, Fc alone beads used as control were incubatedwith neurons in identical wells. Because of the lack of association,most of the beads have
been lost through the washes. C, when neurons are transfected with FLAG-CNTN1, CASPR2–1261-loaded beads bind strongly to the cultured neuron. D,
similarly to control beads, beads loadedwith the non-interacting deletion construct CASPR2-D3–6 did not bind to the neurons transfectedwith CNTN1. Scale
bar 10 m. Microtubule-associated protein (MAP2) was used to outline the neurons.
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arrangements, although a major proportion of the images pro-
cessed are consistent with the arrangement that best fits the solu-
tion scattering data. Third, by expressing the proteins in HEK293
GnTI cells and by using mass spectrometry and SAXS, we were
able to model most of the glycan structures present on the extra-
cellular domain of CASPR2, and demonstrate that they constitute
a significant portion of the protein. Fourth, we show here for the
first timethatCNTN1isanendogenous ligandthatbindsCASPR2
withmicromolaraffinity.Surprisingly,under thesameexperimen-
tal conditions none of the other members of the CNTN family,
including the putative ligand TAG-1, directly interact with
CASPR2.
Structural Characterization—Despite the sequence similar-
ity with NRXN, we present analytical ultracentrifugation, sin-
gle-particle EM, and SAXS data that unambiguously reveal that
the extracellular domain of CASPR2 is monomeric and more
compact in shape than NRXNwith a maximum dimension of
140Å (versus170Å forNRXN), as consistently showed by
SAXS rigid body modeling. In particular, because the central
fibrinogen-like subdomain is unique to CASPR2, we speculate
that this subdomainmay be in part responsible for the compact
three-dimensional shape of the extracellular domain of
CASPR2. Although the identity of the subdomains cannot be
determined by SAXS, EM class-averaged images show a group
of two subdomains likely composed of the last two LNS sub-
domains and a group of three subdomains, likely composed by
the discoidin and the first two LNS subdomains. The fact that
the data from independent solution scattering, analytical ultra-
centrifugation, and single particle EM techniques agree
strongly and overlay well, indicates that these conformations
are native, and likely drive the biological function of CASPR2.
Finally this study directly confirms the monomeric nature of
the autism mutation CASPR2–1253* (5, 6) that we recently
described (7). In this published work, comparative SEC analysis
of CASPR2–1253* and CASPR2–1261 truncation constructs
showed that these two proteins had virtually identical elution
volumes, thus indicating equivalent overall shape andoligomer-
ization state.
Single particle EM suggests that the extracellular domain of
CASPR2 may exhibit some polymorphism in the arrangement
of the individual subdomains. Such flexibility is common to
many proteins with a modular architecture, and may well be
functionally important as it allows the various domains to sam-
ple the three-dimensional volume and structurally adapt to the
engagement withmultiple binding partners and possibly to sig-
nal through the cell membrane. As discussed in more detail
below, the flexibility of the extracellular domain of CASPR2
may be relevant to the micromolar affinity measured for
CNTN1.
Unlike protein crystallography, where extensive glycosyla-
tion usually constitutes a barrier for crystallogenesis due to its
hydration and flexibility, SAXS experiments are not restricted
by the glycosylation degree of protein samples and the contri-
bution of carbohydrate moieties to their overall structure can
be modeled. In this work, both ab initio and rigid body model-
ing procedures take into account the structural and volumetric
contribution of the N-linked glycosylation in the definition of
the final structures (Figs. 2 and 3). In the analysis of these struc-
tural models we highlight the total amount of glycans because
they constitute a large fraction of the mass of the protein and
they likely influence the expression, folding, and solubility of
CASPR2. In our models, we added to our subdomains
Man5GlcNAc2moieties because the protein used for structural
determinations was produced by GnTI cells. However, neu-
rons probably add larger and more complex types of glycans
and therefore the relative mass contributed by the native
N-linked glycosylation is actually much larger than the one
shown in this study. Larger glycosylation will also have an
important impact on the architecture (e.g. flexibility) and ligand
recognition of CASPR2.
CNTN1 Is aNovel Ligand forCASPR2—In testing the binding
affinity of CASPR2 for the CNTN family, which includes the
putative ligand TAG-1 (CNTN2), we found that only CNTN1
binds to the extracellular domain of CASPR2, and it does so
with low affinity (dissociation constant in the micromolar
range). This type of affinity is typical of the extracellular inter-
actome (48), whereas nanomolar affinities are less common in
this class of molecules. The fact that for CNTN1 we could not
measure any association using the six Ig or the four Fn3
domains alone (CNTN1-Ig1–6 or CNTN1-Fn1–4) suggests
that the minimal binding domain requires a combination of Ig
and FN3 domains. Using several deletion constructs of both
CASPR2 and CNTN1 enabled us to identify CNTN1 Ig-5/Fn1
and CASPR2 D1–6 as minimal binding cassette. However, the
requirement for multiple domains is not unusual, especially for
proteins containing Ig and FN3 domains (49). Our data indicate
that the recombinant, purified extracellular domains of
CASPR2, CNTN1, and TAG-1 are correctly folded because
they appear non-aggregating (monodisperse) and without deg-
radation in SEC experiments and SDS-PAGE, and that their
FIGURE 8. CASPR2 does not associate with any other CNTN family mem-
ber.A,BLI curvesofCASPR2andall sixCNTNs, showing thatonlyCNTN1binds
to 30MCASPR2 in these conditions. B,Western blot of all six CNTNs showing
their relative expression and molecular mass. CNTN4 migrates faster than all
other CNTNs because our construct is missing the first Ig domain.
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expression levels were comparable with well folded proteins
with which we have worked in the past (18, 43). Whereas we
cannot exclude that CASPR2 specifically binds to other recep-
tors in neurons, the use of deletion constructs in the neuronal
experiments suggest that CNTN1 is an important endogenous
ligand for CASPR2. Moreover, because of the positive binding,
these experiments show that CASPR2 constructs are well
folded. Remarkably, under the same experimental conditions
TAG-1 (CNTN2) does not seem to associate with CASPR2.
Because the affinity of the CASPR2/TAG-1 pair is currently
unknown, as the binding was detected with non-quantitative
techniques (e.g. immunoprecipitation) (2–4), one possibility is
that the TAG-1/CASPR2 interaction is significantly weaker
than the interactionwithCNTN1, and thereforewe are not able
to detect it by BLI. Another possibility is that the complex asso-
ciates through the interaction with a third protein that is cur-
rently unknown.
Although many open questions on the in vivo functions of
CASPR2 remain, our structural models, the observed interac-
tion with CNTN1, the extensive glycosylation, and the confor-
mational heterogeneity, offer new insights into the structure-
function relationship of these two neuronal proteins.
Moreover, because CNTN1 is expressed by both neurons and
glial cells, the discovery of CNTN1 as a new CASPR2 ligand
suggests a complex role of CASPR2 in the nervous system.
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